Filter
482
Featured
Recommendations
71
Language
Document type
Fact sheets
129
Videos
87
Guidelines
60
Resource Platforms
57
Studies & Reports
47
Manuals
36
Infographics
21
Strategic & Response Plan
13
Training Material
9
Online Courses
8
Situation Updates
7
No document type
6
Brochures
1
App
1
Countries / Regions
Germany
38
Middle East and North Africa
20
Latin America and the Carribbean
18
Brazil
13
Ukraine
11
Russia
11
Africa
10
Syria
9
Yemen
9
East and Southern Africa
8
West and Central Africa
8
South Africa
6
South Sudan
5
Congo, Democratic Republic of
4
China
4
Mozambique
4
Sudan
4
Angola
4
Global
4
United Kingdom
4
Guinea-Bissau
3
India
3
Lebanon
3
Colombia
3
Mali
2
Philippines
2
Argentina
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Burkina Faso
1
Sierra Leone
1
Nigeria
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Ethiopia
1
Ghana
1
Uganda
1
Niger
1
Somalia
1
Kenya
1
Thailand
1
Indonesia
1
Bangladesh
1
Malawi
1
Ecuador
1
Bolivia
1
Nicaragua
1
Myanmar / Burma
1
South–East Asia Region
1
Canada
1
Kazakhstan
1
Vietnam
1
Gabon
1
Jamaica
1
Tunisia
1
South Korea
1
Belarus
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
126
Women & Child Health
19
Clinical Guidelines
9
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
2
Public Health
1
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who
...
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k
...
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des
...
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
La lutte contre l’épidémie de Covid-19 nous montre de manière cinglante que, sur le terrain de l’action en santé publique, les logiques de promotion de la santé sont bel et bien minoritaires. Pendant cette période de crise, la décision
politique et sanitaire se base largement sur un mod
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
Empfehlungen des Robert Koch-Instituts für Alten- und Pflegeeinrichtungen und Einrichtungen für Menschen mit Beeinträchtigungen und Behinderungen und für den öffentlichen Gesundheitsdienst
Stand 7.4.2021
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex
...
Wird ständig aktualisiert
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Zusammen gegen Corona.
Die Meldungen zu Impfstoffen gegen das Coronavirus und die COVID-19-Erkrankung stimmen optimistisch. Möglich ist, dass es noch 2020 erste Zulassungen in Europa geben kann. Hier erfahren Sie mehr zur Impfstoffentwicklung, Impfstofftypen und zur geplanten Organisation und Vert
...
Impfung & COVID-19
recommended
MEDBOX Issue Brief no. 7, Dec. 2020
Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I
...
